Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Cognition Therapeutics, Inc. (CGTX) had Return on Tangible Equity of -105.37% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-25.79M |
|
-- |
|
-- |
|
$50.72M |
|
$-50.72M |
|
$24.94M |
|
$-25.79M |
|
$-25.79M |
|
$-25.79M |
|
$-25.79M |
|
$-25.79M |
|
$-25.79M |
|
$-50.72M |
|
$-50.47M |
|
30.03M |
|
30.03M |
|
$-0.86 |
|
$-0.86 |
|
| Balance Sheet Financials | |
$34.22M |
|
$0.28M |
|
$0.94M |
|
$35.16M |
|
$10.17M |
|
-- |
|
$0.52M |
|
$10.69M |
|
$24.47M |
|
$24.47M |
|
$24.47M |
|
32.16M |
|
| Cash Flow Statement Financials | |
$-16.02M |
|
$-0.15M |
|
$4.52M |
|
$41.56M |
|
$29.92M |
|
$-11.64M |
|
$4.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-105.37% |
|
|
Return on Tangible Equity |
-105.37% |
-73.34% |
|
-105.37% |
|
$0.76 |
|
$-0.54 |
|
$-0.53 |
|